Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol Myers Squibb discloses new FPR2 agonists

Jan. 11, 2021

Dana-Farber Cancer Institute patents EGFR allosteric inhibitors

Jan. 11, 2021

Positive phase IIb data presented for DBI-001 in tinea pedis

Jan. 11, 2021

FDA issues clinical hold letter related to an IND for NL-201

Jan. 11, 2021

CARs with switches

Jan. 11, 2021

FDA clears IND for phase I study of DA-01 in advanced Parkinson's disease

Jan. 11, 2021

Inhaled phage therapy YPT-01 enters phase I/II trial to treat P. aeruginosa in cystic fibrosis

Jan. 11, 2021

JMX-0207 inhibits Zika virus both in vitro and in vivo

Jan. 11, 2021

UCART-19 shows antileukemic activity in heavily pretreated pediatric and adult patients

Jan. 11, 2021

Part 1 topline data reported from trial of SRP-9001 in Duchenne muscular dystrophy

Jan. 8, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...